Geode Capital Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,604
| Closed | -$23.7K | – | 4685 |
|
|
2024
Q1 | $23.7K | Hold |
2,604
| – | – | ﹤0.01% | 4459 |
|
|
2023
Q4 | $15K | Hold |
2,604
| – | – | ﹤0.01% | 4553 |
|
|
2023
Q3 | $20.4K | Buy |
2,604
+1,152
| +79% | +$29K | ﹤0.01% | 4622 |
|
|
2023
Q2 | $77.4K | Hold |
1,452
| – | – | ﹤0.01% | 4407 |
|
|
2023
Q1 | $96.2K | Sell |
1,452
-15
| -1% | -$1.09K | ﹤0.01% | 4348 |
|
|
2022
Q4 | $58K | Sell |
1,467
-4
| -0.3% | -$238 | ﹤0.01% | 4554 |
|
|
2022
Q3 | $105K | Hold |
1,471
| – | – | ﹤0.01% | 4552 |
|
|
2022
Q2 | $79K | Hold |
1,471
| – | – | ﹤0.01% | 4665 |
|
|
2022
Q1 | $187K | Sell |
1,471
-337
| -19% | -$34.8K | ﹤0.01% | 4414 |
|
|
2021
Q4 | $213K | Buy |
1,808
+165
| +10% | +$21.7K | ﹤0.01% | 4446 |
|
|
2021
Q3 | $239K | Buy |
1,643
+260
| +19% | +$43.7K | ﹤0.01% | 4364 |
|
|
2021
Q2 | $283K | Buy |
1,383
+105
| +8% | +$23.4K | ﹤0.01% | 4193 |
|
|
2021
Q1 | $384K | Buy |
+1,278
| New | +$432K | ﹤0.01% | 3896 |
|
|
2020
Q1 | – | Sell |
-62
| Closed | -$10K | – | 4188 |
|
|
2019
Q4 | $10K | Hold |
62
| – | – | ﹤0.01% | 4190 |
|
|
2019
Q3 | $29K | Hold |
62
| – | – | ﹤0.01% | 4115 |
|
|
2019
Q2 | $56K | Buy |
62
+5
| +9% | +$4.78K | ﹤0.01% | 4069 |
|
|
2019
Q1 | $62K | Hold |
57
| – | – | ﹤0.01% | 3979 |
|
|
2018
Q4 | $45K | Hold |
57
| – | – | ﹤0.01% | 4011 |
|
|
2018
Q3 | $77K | Hold |
57
| – | – | ﹤0.01% | 3976 |
|
|
2018
Q2 | $77K | Buy |
+57
| New | +$90.4K | ﹤0.01% | 3925 |
|
|
2017
Q2 | – | Sell |
-4
| Closed | -$13K | – | 4117 |
|
|
2017
Q1 | $13K | Hold |
4
| – | – | ﹤0.01% | 4056 |
|
|
2016
Q4 | $12K | Hold |
4
| – | – | ﹤0.01% | 4025 |
|
|
2016
Q3 | $16K | Hold |
4
| – | – | ﹤0.01% | 4009 |
|
|
2016
Q2 | $29K | Hold |
4
| – | – | ﹤0.01% | 3997 |
|
|
2016
Q1 | $68 | Hold |
4
| – | – | ﹤0.01% | 3916 |
|
|
2015
Q4 | $55K | Buy |
4
+1
| +33% | +$20.2K | ﹤0.01% | 3986 |
|
|
2015
Q3 | $44K | Hold |
3
| – | – | ﹤0.01% | 4023 |
|
|
2015
Q2 | $121K | Hold |
3
| – | – | ﹤0.01% | 3730 |
|
|
2015
Q1 | $120K | Buy |
3
+1
| +50% | +$32K | ﹤0.01% | 3717 |
|
|
2014
Q4 | $52K | Hold |
2
| – | – | ﹤0.01% | 3871 |
|
|
2014
Q3 | $119K | Hold |
2
| – | – | ﹤0.01% | 3718 |
|
|
2014
Q2 | $113K | Hold |
2
| – | – | ﹤0.01% | 3670 |
|
|
2014
Q1 | $170K | Hold |
2
| – | – | ﹤0.01% | 3535 |
|
|
2013
Q4 | $164K | Hold |
2
| – | – | ﹤0.01% | 3487 |
|
|
2013
Q3 | $164K | Hold |
2
| – | – | ﹤0.01% | 3374 |
|
|
2013
Q2 | $185K | Buy |
+2
| New | +$193K | ﹤0.01% | 3259 |
|
Geode Capital Management's YTEN Position: Q2 2024 in Review
Geode Capital Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2024, closing a stake of 2,604 shares — an estimated $23.7K sold.
Geode Capital Management first reported a position in YTEN in Q2 2013 and held it in 36 quarters. The position peaked at $384K in Q1 2021. 0 funds tracked by Wall St. Rank hold YTEN as of Q2 2024.
- Geode Capital Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Geode Capital Management sold 2,604 Yield10 Bioscience, Inc. Common Stock shares in Q2 2024, an estimated $23.7K.
- Geode Capital Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q2 2013 and held it in 36 quarters.
- Geode Capital Management's Yield10 Bioscience, Inc. Common Stock position peaked at $384K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2024.
Based on Geode Capital Management's 13F filing for Q2 2024, filed 9 Aug 2024.